Probiotics in primary prevention of atopic dermatitis

Forum of Nutrition

Volumn 61, Issue , 2009, Pages 117-128

  Ji, Geun Eog ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ANIMAL; ATOPIC DERMATITIS; HUMAN; IMMUNOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANIMALS; DERMATITIS, ATOPIC; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67650215673     PISSN: 16600347     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000212744     Document Type: Article

References (41)

1. Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R, Asher I, Beasley R, Bjorksten B, Burr M, Clayton T, Crane J, Ellwood P. , Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Shah J, Sibbald B, Strachan D, von Mutius E, Weiland SK: Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999;103:125- 138.
2. Strachan DP. Hay fever, hygiene, and household size: Br Med J 1989;299,1259-1260.
3. Flohr C, Pascoe D, Williams HC: Atopic dermatitis and the hygiene hypothesis: too clean to be true. British J Dermatol 2005;152:202-216.
4. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-1745.
5. Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E: The hygiene hypothesis of atopic disease-An extended version. J Pediatr Gastroenterol Nutr 2004;38:378-388.
6. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516-520.
7. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G: Atopy in children of families with an anthropo-sophic lifestyle. Lancet 1999;353:1485-1488.
8. Hattori K, Yamamoto A, Sasai M, Taniuchi S, Kojima T, Kobayashi Y, Iwamoto H, Namba K, Yaeshima T: Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi 2003;52:20- 30.
9. Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, Oldaeus G: Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1174- 1180.
10. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregarrd A: Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003;111:389-395.
11. Isolauri E, Arvola T, Stas Y, Salminen S: Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1605-1610.
12. Mastrandrea F, Conrdduzza G, Serio G, Minardi A, Manelli M, Ardito S, muratore L: Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Eur Ann Allergy Clin Immunol 2004;36:118-122.
13. Rautava S, Kalliomki M, Isolauri E: Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002;109: 119-121.
14. Kallomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001;357:1076-1079.
15. Kopp M V, Hennemuth I, Heinzmann A, Urbanek R: Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008;121:e858-856
16. Presterl E, Kneifel W, Mayer HK, Zehetgruber M, Makristathis A, Graninger W: Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion? Scand J Infect Dis 2001;33:710-714.
17. Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M: Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999;28:1159-1160.
18. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJ, Rosman C, Ploeg RJ, Brink MA, Schaapherder AF, Dejong CH, Wahab PJ, van Laarhoven CJ, van der Harst E, van Eijck CH, Cuesta MA, Akkermans LM, Gooszen HG: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:651-659.
19. Taylor AL, Dunstan JA, Prescott SL: Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J Allergy Clin Immunol. 2007;119:184-191.
20. Osborn DA, Sinn JK: Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007;17,CD006475.
21. Lee J, Seto D, Bielory L: Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008;121, 116-121
22. Van de Water J, Keen CL, Gershwin ME: The influence of chronic yogurt consumption on immunity. J Nutr 1999;129 Suppl 7:1492-1495.
23. Kim H, Ji GE: Effect of viability and integrity of Bifidobacterium on suppression of allergy in mice. J Microbiol Biotechnol 2006;16:1010-1016.
24. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF: Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004;145:612-616.
25. Salminen S, Isolauri E, Salminen E: Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 1996;70, 347-358.
26. Inoue R, Nishio A, Fukushima Y, Ushida K: Oral treatment with probiotic Lactobacillus johnsonii NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC/ Nga. Br J Dermatol 2007;156:499-509.
27. Williamson E, Westrich GM, Viney JL: Modulating dendritic cells to optimize mucosal immunization protocols. J Immunol 1999;163:3668-3675.
28. Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101:455- 458.
29. Blander JM, Medzhitov R: Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006;440:808-812.
30. Corthésy B, Gaskins HR, Mercenier A: Cross-talk between probiotic bacteria and the host immune system. J Nutr 2007;137:781S-790S.
31. Koizumi S, Wakita D, Sato T, Mitamura R, Izumo T, Shibata H, Kiso Y, Chamoto K, Togashi Y, Kitamura H, Nishimura T: Essential role of Toll-like receptors for dendritic cell and NK1.1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84. Immunol Lett 2008;120:14-19.
32. Iliev ID, Tohno M, Kurosaki D, Shimosato T, He F, Hosoda M, Saito T, Kitazawa H: Immunostimulatory oligodeoxynucleotide containing TTTCGTTT motif from Lactobacillus rhamnosus GG DNA potentially suppresses OVA-specific IgE production in mice. Scand J Immunol 2008;67:370-376.
33. Hisbergues M, Magi M, Rigaux P, Steuve J, Garcia L, Goudercourt D, Pot B, Pestel J, Jacquet A: In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria. Clin Exp Allergy 2007;37:1286-1295.
34. Prescott SL, Bjorksten B: Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 2007;120:255-262.
35. Scheinecker C, McHugh R, Shevach EM, Germain RN: Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med 2002;196:1079- 1090.
36. Veckman V, Miettinen M, Pirhonen J, Siren J, Matikainen S, Julkunen I: Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J Leukoc Biol 2004;75:764-771.
37. Rook GAW, Brunet LR: Microbes, immunoregula-tion, and the gut. Gut 2005;54:317-320.
38. Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, Kaiserlian D: Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur J Immunol 2004;34:2520-2528.
39. Kim H, Kwack K, Kim DY, Ji GE: Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model. FEMS Immunol Med Mic 2005;45:259-267.
40. Torii A, Torii S, Fujiwara S, Tanaka H, Inagaki N, Nagai H: Lactobacillus acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol Int 2007;56:293-301.
41. Ohno H, Tsunemine S, Isa Y, Shimakawa M, Yamamura H: Oral administration of Bifidobacterium bifidum G9-1 suppresses total and antigen specific immunoglobulin E production in mice. Biol Pharm Bull 2005;28:1462-1466.